Clinical Investigator
Koen van Rossem, MD, PhD
Barrier Therapeutics/ Stiefel, a GSK Company
Total Trials
1
As PI
0
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 21
Phase 31
Trial Status
Completed1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Ichthyosis, Lamellar
Studydirector
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Barrier Therapeutics/ Stiefel, a GSK Company
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
5 similar investigators found
Emma Guttman-Yassky, MD, PhD
Mt. Sinai Hospital Department of Dermatology
1 trials
Shared therapeutic areas:
Ichthyosis, Lamellar
Similarity Score30%
Amy Paller, MD
Northwestern University Department of Dermatology
1 trials
Shared therapeutic areas:
Ichthyosis, Lamellar
Similarity Score30%
Chiaverini Christine, Dr
CHU de Nice - Service de dermatologie
1 trials
Shared therapeutic areas:
Ichthyosis, Lamellar
Similarity Score30%
Philip Fleckman, MD
University of Washington
1 trials
Shared therapeutic areas:
Ichthyosis, Lamellar
Similarity Score30%
Keith A. Choate, MD
Yale University
1 trials
Shared therapeutic areas:
Ichthyosis, Lamellar
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Ichthyosis, Lamellar
All 1 trials loaded